H&R Reveals Preliminary Q1-2024 Results: Key Insights Unveiled

• H&R GmbH & Co. KGaA published preliminary results for Q1-2024
• EBITDA improved by almost 50% to EUR 21.3 million compared to Q1-2023
• Sales of EUR 337.0 million, around 3.4% less than the previous year
• ChemPharm SALES segment had positive development, matching previous year's sales
• ChemPharm REFINING segment faced pressure with lower volumes and competitive product prices
• Operating cash flow decreased to EUR 11.4 million in Q1-2024, primarily due to raw material price development

The next important date, Publication of Quarterly Report (Cut-off date Q1), at H&R is on 15.05.2024.

The price of H&R at the time of the news was 4,9000EUR and was up +2,94 % compared with the previous day.
13 minutes after the article was published, the price was 4,9600EUR this corresponds to a plus of +1,22 % since publication.

H&R

0,00 %

+2,93 %

+0,72 %

-0,61 %

-8,98 %

-27,93 %

-32,37 %

-32,42 %

-15,55 %

ISIN:DE000A2E4T77WKN:A2E4T7

• Intraday
• 5 Tage
• 1 Monat
• 3M
• 1 Jahr
• 3J
• 5J
• 10J
• Max